Campbell v. Lupis

CourtDistrict Court, D. Connecticut
DecidedApril 1, 2024
Docket3:22-cv-01654
StatusUnknown

This text of Campbell v. Lupis (Campbell v. Lupis) is published on Counsel Stack Legal Research, covering District Court, D. Connecticut primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Campbell v. Lupis, (D. Conn. 2024).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF CONNECTICUT

---------------------------------------------------------------- x MILTON CAMPBELL, : : Plaintiff, : : RULING ON MOTION -against- : FOR SUMMARY : JUDGMENT FRANCESCO LUPIS, : : 22-CV-1654 (VDO) Defendant. : --------------------------------------------------------------- x VERNON D. OLIVER, United States District Judge: Plaintiff Milton Campbell, a sentenced inmate incarcerated at MacDougall-Walker Correctional Institution (“MacDougall”) in Suffield, Connecticut, brings this action pro se and in forma pauperis under 42 U.S.C. § 1983. Plaintiff contends that the defendant, Dr. Lupis, was deliberately indifferent to his serious medical needs. He seeks damages and injunctive relief in the form of an order that he be treated by a different doctor. Defendant has filed a Motion for Summary Judgment. For the following reasons, Defendant’s Motion is granted. I. FACTS1 Plaintiff was confined at MacDougall during the time relevant to this action, December 2021 through October 2022.2 Def.s’ Local Rule 56(a)1 Stmt., Doc. No. 25-2, ¶¶ 6, 8. Dr. Lupis is assigned to MacDougall where he provides generalized medical care to

inmates with a focus on chronic illnesses including diabetes types 1 and 2. Id. ¶ 18. He has treated Plaintiff for hypertension, chronic lumbar back pain, joint pain in his left hand, elevated creatinine, and type 2 diabetes which is controlled with renal complications. Id. ¶ 19. Inmates with diabetes are treated according to community standards with diet and insulin or insulin alone. Id. ¶ 20. Type 2 diabetes is a chronic disease characterized by high levels of blood sugar. Id. ¶ 21. It is more common that Type 1 diabetes which also is characterized by high blood sugar levels. Id. Diabetes is routinely evaluated by several laboratory tests. Id. ¶ 22.

1 The facts are taken from the parties’ Local Rule 56(a) Statements and supporting exhibits. Local Rule 56(a)2 requires the party opposing summary judgment to submit a Local Rule 56(a)2 Statement which contains separately numbered paragraphs corresponding to the Local Rule 56(a)1 Statement and indicating whether the opposing party admits or denies the facts set forth by the moving party. Each denial must include a specific citation to an affidavit or other admissible evidence. D. Conn. L. Civ. R. 56(a)3. Defendant informed the plaintiff of this requirement. See Notice to Self-Represented Litigant Concerning Motion for Summary Judgment as required by Local Rule of Civil Procedure 56(b) Doc. No. 25-9. Although Plaintiff filed a Local Rule 56(a)2 Statement, he has not provided a citation to admissible evidence in support of each denial. The fact that the plaintiff is unrepresented does not excuse him from complying with the court’s procedural and substantive rules. See Evans v. Kirkpatrick, No. 08-CV-6358T, 2013 WL 638735, at *1 (W.D.N.Y. Feb. 20, 2013) (citing Treistman v. Federal Bureau of Prisons, 470 F.3d 471, 477 (2d Cir. 2006)); see also Jackson v. Onondaga Cnty., 549 F. Supp. 2d 204, 214 (N.D.N.Y. 2008) (“when a plaintiff is proceeding pro se, ‘all normal rules of pleading are not absolutely suspended” (citation omitted). Thus, the defendants’ facts, where supported by evidence of record and not contradicted by admissible evidence provided by the plaintiff, are deemed admitted. See D. Conn. L. Civ. R. 56(a)3 (“Failure to provide specific citations to evidence in the record as required by this Local Rule may result in the Court deeming admitted certain facts that are supported by the evidence in accordance with Local Rule 56(a)1, or in the Court imposing sanctions....”).

2 Plaintiff disputes this fact, stating in his declaration that he was transferred to Carl Robinson Correctional Institution and back to MacDougall. Plaintiff provides no date for this transfer, stating only that it occurred recently. However, the declaration is dated January 5, 2023 but was not signed until January 3, 2024 and filed the following day. Thus, the Court cannot discern when the transfer may have occurred. Regardless, Defendants have submitted a copy of Plaintiff’s RT67 Movement History which shows that, except for a brief hospital stay, Plaintiff was confined at MacDougall from November 2009 through September 14, 2023, the date of the report. See Def.s’ Mem. Attachment B, Decl. of Michelle DeVeau, Ex. A, Doc. No. 25-3 at 6. As Plaintiff does not argue that he was not confined at MacDougall during the time relevant to his claims, his objection is immaterial. Diabetes is a lifelong illness. Id. ¶ 23. Type 1 diabetes is caused by an autoimmune reaction that destroys the insulin-producing cells in the pancreas. Id. ¶ 29. It develops early in life and is treated with lifelong insulin injections. Id. ¶¶ 30-31. Type 2 diabetes is caused by insulin

resistance which reduces the effectiveness of insulin. Id. ¶ 29. It develops later in life and can be managed with oral medications, diet and exercise, and sometimes insulin. Id. ¶¶ 30-31. Treatment for type 2 diabetes usually begins with weight reduction through diet and exercise. Id. For some people, aggressive weight loss, exercise, and a healthy diet are not sufficient to control type 2 diabetes. Id. ¶ 25. In this case, medications also are prescribed to control blood sugar levels. Id. Often, both short-acting and long-acting insulin are prescribed. Id. ¶ 26. A troubling side effect of insulin is low blood sugar which can cause sudden weakness,

sweating, and unclear thinking. Id. ¶ 27. Persons with type 2 diabetes also frequently take medications to reduce the risk or slow the onset of complications of diabetes, such as kidney disease, low cholesterol, and low blood pressure. Id. ¶ 28. Plaintiff has been prescribed three types of insulin, Novolin R, a man-made insulin structurally identical to the insulin produced by the pancreas, Humulin R, an intermediate- acting insulin, and Lantus, a long-acting insulin. Id. ¶¶ 39-41. He has been prescribed acetaminophen, or Tylenol, for pain. Id. ¶ 42. He has never been prescribed ibuprofen for pain

as this medication can cause kidney damage. Id. ¶¶ 42-43. In October 2021, Plaintiff weighed 139 pounds. Id. ¶ 46. In November 2021, he weighed 131 pounds. Doc. No. 26 at 1379. 3 In December 2021, Dr. Lupis noted that Plaintiff’s blood

3 The page numbers cited in this ruling regarding any documents that have been electronically filed refer to the page numbers imprinted by the electronic case filing system on the header of the documents and not to the page numbers on the original documents, if any. sugar levels were controlled with his diet and were within normal range. Doc. No. 25-2 ¶ 44. Exercising his professional judgment, Dr. Lupis discontinued Plaintiff’s insulin injections. Id. During this time, Plaintiff continued to be monitored for kidney disease, blood pressure, and

weight. Id. ¶ 45. On February 13, 2022, Plaintiff reported to the medical unit complaining of frequent urination and weight loss. Id. ¶ 47. He weighed 112.1 pounds. Id. ¶ 48. Dr. Lupis reinstated Plaintiff’s insulin the same day. Id. ¶ 49. Because of the poor results without insulin, Dr. Lupis suspected that Plaintiff might have type 1 diabetes and not type 2. Id. ¶ 50. He continued to monitor Plaintiff’s daily blood sugar levels and blood pressure and noted that both were normal. Id.

In June 2022, Dr. Lupis ordered tests to determine whether Plaintiff had been properly diagnosed as a type 2 diabetic. Id. ¶ 51. The test results showed a diagnosis of type 1 diabetes and Dr. Lupis adjusted Plaintiff’s medication. Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Giordano v. MARKET AMERICA, INC.
599 F.3d 87 (Second Circuit, 2010)
Day v. Chaplin
354 F. App'x 472 (Second Circuit, 2009)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Porter v. Nussle
534 U.S. 516 (Supreme Court, 2002)
Woodford v. Ngo
548 U.S. 81 (Supreme Court, 2006)
Jones v. Bock
549 U.S. 199 (Supreme Court, 2007)
Hill v. Curcione
657 F.3d 116 (Second Circuit, 2011)
Hathaway v. Coughlin
99 F.3d 550 (Second Circuit, 1996)
Chance v. Armstrong
143 F.3d 698 (Second Circuit, 1998)
Shelley Weinstock v. Columbia University
224 F.3d 33 (Second Circuit, 2000)
Christopher Graham v. Long Island Rail Road
230 F.3d 34 (Second Circuit, 2000)
Neal v. Goord
267 F.3d 116 (Second Circuit, 2001)
Walker v. Schult
717 F.3d 119 (Second Circuit, 2013)
Wright v. Goord
554 F.3d 255 (Second Circuit, 2009)
MacIas v. Zenk
495 F.3d 37 (Second Circuit, 2007)
Jackson v. Onondaga County
549 F. Supp. 2d 204 (N.D. New York, 2008)

Cite This Page — Counsel Stack

Bluebook (online)
Campbell v. Lupis, Counsel Stack Legal Research, https://law.counselstack.com/opinion/campbell-v-lupis-ctd-2024.